|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Acer Therapeutics Inc. (ACER)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-08-01 Purchase |
2018-08-22 4:22 pm |
Acer Therapeutics Inc. | ACER | TVM Life Science Ventures VII L.P. Birner Hubert Marengere Luc Fischer Stefan SCHUHSLER HELMUT Beeby Reshentha Leatt Gary Director, 10% Owner |
275,000 | $18 | $4,950,000 | 1,697,709 (Indirect) |
View |
| 2017-12-12 Purchase |
2018-01-12 2:33 pm |
Acer Therapeutics Inc. | ACER | TVM Life Science Ventures VI GmbH & Co KG TVM Life Science Ventures VI LP TVM Life Science Ventures VII L.P. Birner Hubert Marengere Luc Fischer Stefan SCHUHSLER HELMUT Wanless Mark Leatt Gary Director, 10% Owner |
333,333 | $12 | $3,999,996 | 1,422,709 (Indirect) |
View |
| 2017-12-14 Purchase |
2017-12-18 4:01 pm |
Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director |
2,000 | $12 | $24,000 | 13,905 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2018-12-04 Option Award |
2018-12-06 6:20 pm |
N/A 2028-12-04 |
Acer Therapeutics Inc. | ACER | Jutt-Eghbali Salma Chief Commercial Officer |
60,000 | $22.18 | 60,000 (Direct) |
View |
| 2018-04-20 Option Award |
2018-04-23 4:32 pm |
N/A 2028-04-20 |
Acer Therapeutics Inc. | ACER | Joseph Donald Chief Legal Officer and Secy |
60,000 | $18.53 | 60,000 (Direct) |
View |
| 2017-10-04 Option Award |
2017-10-06 4:11 pm |
N/A 2027-10-04 |
Acer Therapeutics Inc. | ACER | Andrews William T. Chief Medical Officer |
100,000 | $15.34 | 100,000 (Direct) |
View |
| 2017-10-04 Option Award |
2017-10-06 4:11 pm |
N/A 2027-10-04 |
Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director |
6,000 | $15.34 | 6,000 (Direct) |
View |
| 2017-10-04 Option Award |
2017-10-06 4:11 pm |
N/A 2027-10-04 |
Acer Therapeutics Inc. | ACER | GRIFFIN MICHELLE RENEE Director |
9,000 | $15.34 | 9,000 (Direct) |
View |
| 2017-10-04 Option Award |
2017-10-06 4:10 pm |
N/A 2027-10-04 |
Acer Therapeutics Inc. | ACER | DUNN JOHN MICHAEL Director |
6,000 | $15.34 | 6,000 (Direct) |
View |
| 2017-10-04 Option Award |
2017-10-06 4:10 pm |
N/A 2027-10-04 |
Acer Therapeutics Inc. | ACER | Amello Jason Director |
9,000 | $15.34 | 9,000 (Direct) |
View |
| 2017-10-04 Option Award |
2017-10-06 4:10 pm |
N/A 2027-10-04 |
Acer Therapeutics Inc. | ACER | PALMIN HARRY S CFO |
67,600 | $15.34 | 67,600 (Direct) |
View |
| 2017-10-04 Option Award |
2017-10-06 4:10 pm |
N/A 2027-10-04 |
Acer Therapeutics Inc. | ACER | Schelling Chris CEO |
46,000 | $15.34 | 46,000 (Direct) |
View |
| 2017-09-19 Other |
2017-09-27 6:34 pm |
N/A N/A |
Acer Therapeutics Inc. | ACER | TVM Life Science Ventures VI GmbH & Co KG TVM Life Science Ventures VI LP TVM Life Science Ventures VII L.P. Birner Hubert Marengere Luc Fischer Stefan SCHUHSLER HELMUT Wanless Mark Leatt Gary Director, 10% Owner |
663,782 | $0 | 1,172,709 (Indirect) |
View |
| 2017-09-19 Other |
2017-09-27 6:34 pm |
N/A N/A |
Acer Therapeutics Inc. | ACER | TVM Life Science Ventures VI GmbH & Co KG TVM Life Science Ventures VI LP TVM Life Science Ventures VII L.P. Birner Hubert Marengere Luc Fischer Stefan SCHUHSLER HELMUT Wanless Mark Leatt Gary Director, 10% Owner |
227,485 | $0 | 1,172,709 (Indirect) |
View |
| 2017-09-19 Other |
2017-09-27 6:34 pm |
N/A N/A |
Acer Therapeutics Inc. | ACER | TVM Life Science Ventures VI GmbH & Co KG TVM Life Science Ventures VI LP TVM Life Science Ventures VII L.P. Birner Hubert Marengere Luc Fischer Stefan SCHUHSLER HELMUT Wanless Mark Leatt Gary Director, 10% Owner |
1,172,709 | $0 | 1,172,709 (Indirect) |
View |
| 2017-09-19 Other |
2017-09-21 5:28 pm |
N/A 2026-04-05 |
Acer Therapeutics Inc. | ACER | Steiner Robert D Chief Medical Officer |
40,000 | $2.55 | 40,000 (Direct) |
View |
| 2017-09-19 Other |
2017-09-21 5:28 pm |
N/A N/A |
Acer Therapeutics Inc. | ACER | PALMIN HARRY S CFO |
125,000 | $0 | 125,000 (Direct) |
View |
| 2017-09-19 Other |
2017-09-21 5:28 pm |
N/A N/A |
Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director |
11,905 | $0 | 21,000 (Direct) |
View |
| 2017-09-19 Other |
2017-09-21 5:28 pm |
N/A 2025-10-19 |
Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director |
21,000 | $2.55 | 21,000 (Direct) |
View |
| 2017-09-19 Other |
2017-09-21 5:25 pm |
N/A N/A |
Acer Therapeutics Inc. | ACER | DUNN JOHN MICHAEL Director |
5,952 | $0 | 16,000 (Direct) |
View |
| 2017-09-19 Other |
2017-09-21 5:25 pm |
N/A 2025-10-19 |
Acer Therapeutics Inc. | ACER | DUNN JOHN MICHAEL Director |
16,000 | $2.55 | 16,000 (Direct) |
View |
| 2017-09-19 Other |
2017-09-21 5:23 pm |
N/A N/A |
Acer Therapeutics Inc. | ACER | Schelling Chris CEO |
1,750,000 | $0 | 1,750,000 (Direct) |
View |
|
© 2005-2018 SecForm4.Com All rights reserved. Archives: 2018 2017 2016 2015 2014 2013 ... Sat, 15 Dec 2018 03:12:31 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |